Ivana Magovcevic
Affiliations
- at Acrivon Therapeutics Inc. (ACRV), 2025-06-17
- President And Ceo at Vigil Neuroscience Inc. (VIGL), 2025-03-04
- at Quanterix Corp (QTRX), 2025-01-06
- Director at Aeglea Biotherapeutics Inc. (AGLE), 2023-06-30
- Director at Absci Corp (ABSI), 2022-06-10
- Director at Applied Genetic Technologies Corp (AGTC), 2021-12-02
- Evp; Chief Operating Officer at Dyax Corp (DYAX), 2013-03-29
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| VIGL | $1.68 | 5,000 | $8,400.00 | 222,687 | 2024-12-19 | Filing |
| VIGL | $1.67 | 5,000 | $8,350.00 | 217,687 | 2024-12-18 | Filing |
| VIGL | $2.34 | 5,000 | $11,700.00 | 212,687 | 2024-12-05 | Filing |
| VIGL | $3.75 | 4,000 | $15,000.00 | 207,687 | 2023-11-20 | Filing |
| VIGL | $3.94 | 1,000 | $3,940.20 | 203,687 | 2022-05-03 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| DYAX | $4.00 | 7,860 | $31,440.00 | 40,625 | 2013-03-06 | Filing |
| DYAX | $4.01 | 3,021 | $12,114.21 | 48,485 | 2013-03-06 | Filing |
| DYAX | $4.00 | 204,478 | $817,912.00 | 51,506 | 2013-03-06 | Filing |
| DYAX | $3.24 | 4,015 | $13,009.00 | 48,485 | 2013-02-25 | Filing |
| DYAX | $2.49 | 7,395 | $18,413.55 | 0 | 2010-06-25 | Filing |